Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication (Q40220112)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2006

Language	Label	Description	Also known as
English	Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication	scientific article published on January 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

12

object named as

John D Morrey

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Raymond F. Schinazi

11

object named as

Raymond F Schinazi

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Lieven J Stuyver

1

object named as

Lieven J Stuyver

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Phillip A Furman

14

object named as

Phillip A Furman

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Laurent Hollecker

5

object named as

Laurent Hollecker

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Stefania Lostia

6

object named as

Stefania Lostia

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Tamara R McBrayer

2

object named as

Tamara R McBrayer

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Phillip M Tharnish

3

object named as

Phillip M Tharnish

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

author name string

Jeremy Clark

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Tammy Nachman

7

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Jason Grier

8

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Matthew A Bennett

9

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Meng-Yu Xie

10

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Justin L Julander

13

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Michael J Otto

15

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Antiviral Chemistry & Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

79-87

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Multiple drug effect analysis with confidence interval

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Efficient initiation of HCV RNA replication in cell culture

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Combination therapy with interferon-alpha and ribavirin for hepatitis C: practical treatment issues

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Antiviral drugs in current clinical use.

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

New therapeutic strategies for hepatitis C.

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Synthesis and Antiviral Evaluation of 2′,3′-Dideoxy-2′-fluoro-3′-C-hydroxymethyl-β-D-arabinofuranosyl Pyrimidine Nucleosides

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Expression of hepatitis C virus NS5B protein: characterization of its RNA polymerase activity and RNA binding

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

In vitro RNA replication directed by replicase complexes isolated from the subgenomic replicon cells of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Mitochondrial toxicity of antiviral drugs

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Biochemical and kinetic analyses of NS5B RNA-dependent RNA polymerase of the hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Nm 283, an efficient prodrug of the potent anti-HCV agent 2'-C-methylcytidine

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Structure of human dCK suggests strategies to improve anticancer and antiviral therapy

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Canonical 3'-deoxyribonucleotides as a chain terminator for HCV NS5B RNA-dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Antiviral activities and cellular toxicities of modified 2',3'-dideoxy-2',3'-didehydrocytidine analogues

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Dynamics of Subgenomic Hepatitis C Virus Replicon RNA Levels in Huh-7 Cells after Exposure to Nucleoside Antimetabolites

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Ribonucleoside Analogue That Blocks Replication of Bovine Viral Diarrhea and Hepatitis C Viruses in Culture

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

HCV RNA-dependent RNA polymerase as a target for antiviral development

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Nucleosides. 123. Synthesis of antiviral nucleosides: 5-substituted 1-(2-deoxy-2-halogeno-.beta.-D-arabinofuranosyl)cytosines and -uracils. Some structure-activity relationships

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Natural history of HCV infection

1 reference

https://api.crossref.org/works/10.1177%2F095632020601700203

21 January 2018

Identifiers

10.1177/095632020601700203

1 reference

https://api.fatcat.wiki/v0/release/ureuk4ugfrbcjl5axcf3s36lei

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_ureuk4ugfrbcjl5axcf3s36lei

1 reference

https://api.fatcat.wiki/v0/release/ureuk4ugfrbcjl5axcf3s36lei

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/ureuk4ugfrbcjl5axcf3s36lei

30 July 2022

based on heuristic

mapped directly with Wikidata item

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40220112&oldid=2210727040"